alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# C_2020161EN.01000602.xml

| 11.5.2020 | EN | Official Journal of the European Union | C 161/6 |
| --- | --- | --- | --- |

11.5.2020

EN

Official Journal of the European Union

C 161/6

---

Judgment of the Court (Fourth Chamber) of 4 March 2020 — European Union Intellectual Property Office v Equivalenza Manufactory, SL

(Case C-328/18 P) (1)

(Appeal - EU trade mark - Regulation (EC) No 207/2009 - Article 8(1)(b) - Likelihood of confusion - Assessment of the similarity of the signs at issue - Global assessment of the likelihood of confusion - Consideration of marketing circumstances - Counteraction of a phonetic similarity through visual and conceptual differences - Conditions for counteraction)

(2020/C 161/08)

Language of the case: Spanish

Parties

Appellant: European Union Intellectual Property Office (EUIPO) (represented by: J.F. Crespo Carrillo, acting as Agent)

Other party to the proceedings: Equivalenza Manufactory, SL (represented by: G. Macías Bonilla, G. Marín Raigal and E. Armero Lavie, abogados)

Operative part of the judgment

The Court:

| 1. | Sets aside the judgment of the General Court of the European Union of 7 March 2018, Equivalenza Manufactory v EUIPO — ITM Entreprises (BLACK LABEL BY EQUIVALENZA) (T-6/17, not published, EU:T:2018:119); |
| --- | --- |

1.

Sets aside the judgment of the General Court of the European Union of 7 March 2018, Equivalenza Manufactory v EUIPO — ITM Entreprises (BLACK LABEL BY EQUIVALENZA) (T-6/17, not published, EU:T:2018:119);

| 2. | Dismisses the action for annulment brought by Equivalenza Manufactory SL before the General Court of the European Union in Case T–6/17; |
| --- | --- |

2.

Dismisses the action for annulment brought by Equivalenza Manufactory SL before the General Court of the European Union in Case T–6/17;

| 3. | Orders Equivalenza Manufactory SL to bear its own costs relating both to the proceedings at first instance in Case T-6/17 and to the appeal proceedings and to pay the costs incurred by the European Union Intellectual Property Office (EUIPO) in both of those proceedings. |
| --- | --- |

3.

Orders Equivalenza Manufactory SL to bear its own costs relating both to the proceedings at first instance in Case T-6/17 and to the appeal proceedings and to pay the costs incurred by the European Union Intellectual Property Office (EUIPO) in both of those proceedings.

---

(1)  OJ C 341, 24.9.2018.

---
[Federal Register Volume 66, Number 11 (Wednesday, January 17, 2001)]
[Notices]
[Page 3978]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-1265]


-----------------------------------------------------------------------

DEPARTMENT OF AGRICULTURE

Agricultural Research Service


Notice of Intent to Grant Exclusive License

AGENCY: Agricultural Research Service, USDA.

ACTION: Notice of intent.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the U.S. Department of 
Agriculture, Agricultural Research Service (USDA), intends to grant to 
Viral Therapeutics of Ithaca, New York, an exclusive license to the 
invention disclosed in U.S. Patent No. 6,017,713 issued on January 25, 
2000, entitled ``Ferritin Formation as a Predictor of Iron Availability 
in Foods.'' Notice of Availability was published in the Federal 
Register on November 3, 1999.

DATES: Comments must be received on or before March 19, 2001.

ADDRESSES: Send comments to: USDA, ARS, Office of Technology Transfer, 
5601 Sunnyside Avenue, Rm. 4-1158, Beltsville, Maryland 20705-5131.

FOR FURTHER INFORMATION CONTACT: June Blalock of the Office of 
Technology Transfer at the Beltsville address given above; telephone: 
301-504-5989.

SUPPLEMENTARY INFORMATION: The Federal Government's patent rights in 
this invention are assigned to the United States of America, as 
represented by the Secretary of Agriculture. It is in the public 
interest to so license the U.S. Government's rights in this invention 
as Viral Therapeutics has submitted a complete and sufficient 
application for a license. The prospective exclusive license will be 
royalty-bearing and will comply with the terms and conditions of 35 
U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be 
granted unless, within sixty (60) days from the date of this published 
Notice, the Agricultural Research Service receives written evidence and 
argument which establishes that the grant of the license would not be 
consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7.

Richard M. Parry, Jr.,
Assistant Administrator.
[FR Doc. 01-1265 Filed 1-16-01; 8:45 am]
BILLING CODE 3410-03-P
EXHIBIT 10.1





|     |  |  |  |  |  |                                                                                                    
|---- |  |  |  |  |  | ---------------------------------------------------------------------------------------------------
|LOGO |  |  |  |  |  | 20 William Street, Suite 310 Wellesley, MA 02481 781-304-1800 phone 781-304-1701 fax www.stream.com

May 6, 2009

Mr. R. Scott Murray

Stream Global Services, Inc.

20 William Street, Suite 310

Wellesley, MA 02481

Dear Scott:

Stream Global Services, Inc., a Delaware corporation (the Company), and you hereby agree to
amend the employment agreement dated as of July 15, 2008, as amended on December 29, 2008, by and between the Company and you (the Agreement), as follows:

The last sentence in Section 3.4 is deleted in its entirety and replaced by inserting at the end the following:

Up to 40 hours of unused vacation time accrued by the Executive at the end of any fiscal year shall be carried over in full to the next year.

Except as modified by this letter or by other intervening amendments, all other terms and conditions of the Agreement shall remain in full force and effect. This letter may be executed in counterparts, each of which
shall be deemed to be an original, and all of which shall constitute one and the same document.

STREAM GLOBAL SERVICES,
INC.

By:  /s/    Sheila M.
Flaherty

Sheila M. Flaherty

Chief Legal and Administrative Officer

Acknowledged and agreed:

/s/    R. Scott
Murray

R. Scott Murray

Date
```

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2261 Introduced in House (IH)]

<DOC>

116th CONGRESS
  1st Session
                                H. R. 2261

To amend title 11 of the United States Code, to allow full subrogation, 
 including subrogation to the priority rights of the United States, of 
               claims for the payment of customs duties.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             April 10, 2019

 Mr. King of New York (for himself, Mr. Meeks, Mr. Foster, Mr. Welch, 
  Mr. Vela, and Mr. Gonzalez of Texas) introduced the following bill; 
          which was referred to the Committee on the Judiciary

_______________________________________________________________________

                                 A BILL

 
To amend title 11 of the United States Code, to allow full subrogation, 
 including subrogation to the priority rights of the United States, of 
               claims for the payment of customs duties.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Customs Business Fairness Act of 
2019''.

SEC. 2. AMENDMENT.

    Section 507(d) of title 11, United States Code, is amended by 
inserting ``excluding subparagraph (F)'' after ``(a)(8)''.

SEC. 3. EFFECTIVE DATE; APPLICATION OF AMENDMENT.

    (a) Effective Date.--Except as provided in subsection (b), this Act 
and the amendment made by this Act shall take effect on the date of the 
enactment of this Act.
    (b) Application of Amendment.--The amendment made by this Act shall 
not apply with respect to cases commenced under title 11 of the United 
States Code before the date of the enactment of this Act.
                                 <all>
```
<PAGE>


                                                                    Exhibit 99.2


                            CERTIFICATION PURSUANT TO

                             18 U.S.C. SECTION 1350,

                             AS ADOPTED PURSUANT TO

                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Annual Report of Atlas America Public #10 Ltd. (the
"Partnership") on Form 10-KSB for the period ended December 31, 2002 as filed
with the Securities and Exchange Commission on the date hereof (the "Report"),
I, Nancy J. McGurk, Chief Financial Officer of the Managing General Partner,
certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the
Sarbanes-Oxley Act of 2002, that:

(1)      The Report fully complies with the requirements of section 13 (a) or 15
         (d) of the Securities Exchange Act of 1934; and

(2)      The information contained in the Report fairly presents, in all
         material respects, the financial condition and results of operations of
         the Partnership.




/s/ Nancy J. McGurk
-------------------

Nancy J. McGurk
Chief Financial Officer of the Managing General Partner
March 28, 2003
| 1.   | The      Report fully complies with the requirements of Section 13(a) of the      Securities Exchange Act of 1934;and |
|----------------|-----------------------------------------------------------------------------------------------------------------------|

| 2.   | The      information contained in the Report fairly presents, in all material      respects, the consolidated financial condition of the Company as of the      dates presented and the consolidated result of operations of the Company      for the periods presented. |
|----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| By:    | /s/Anusha Kumar                                                            |
|--------|---------------------------------------------------------------------------------|
|   |                                                                            |
| Name:  | Anusha      Kumar                                                               |
|   |                                                                            |
| Title: | Principal      Executive Officer, Principal      Financial Officer and Director |
|   |                                                                            |
| Date:  | June      15, 2009                                                              |
#### Thompson *v.*Hall and others.1

*Circuit Court, E. D. New York.*

July 24, 1885.

1.- Patents for Inventions.

Upon, a full consideration, of the evidence in this case, *held,*that Moses 0. Johnson was not the first inventor of the combination described in the patent No. 282,975, of October 5,1880, to Henry G. Thompson, as assignee of Johnson.

■2. Same.

The decision of this case turned on a question of time, as to when a certain model was made, and, the evidence showing it to have been made at a period subsequent to that alleged by plaintiff, it was held that his assignor was not the first inventor of the improvements claimed by the patent.

In Equity.

*Horace Barnard,*for complainant.

*Amos Broadnax*and *J. Edgar Bull,*for defendants.

1

reported by Cliarleg C. Linthicum, Esq., of the Chicago bar.

Benedict, J.

This action is founded upon letters patent No. 282,-. 975, dated October 5, 1880, issued to Henry G. Thompson, assignee of Moses C. Johnson, for an improvement in cutting-pliers. The bill charges infringement, and prays for damages and an injunction.

■ The question at issue is whether the combination described in the plaintiff’s patent was invented by Moses 0. Johnson while an employe of a corporation styled “The Interchangeable Tool Company,” which corporation .was engaged in the manufacture of cutting-pliers under a parent issued to the defendant Hall, then the president of that corporation. In support of the averment that Moses C. Johnson was the first inventor of the combination in question the plaintiff produces a model, known in the case as “Defendants’Exhibit C,” which model embodies the invention in question, and was made, as the plaintiff •has sought to prove, while Johnson was in the employ of the Interchangeable Tool Company. On the other hand, the defendants assert, -and have sought to prove, that this model was not made by Johnson .while employed by the Interchangeable Tool Company, but after John*907son bad been discharged from that employment, and for the purposé of supporting a fraudulent claim to an invention really discovered by the defendant Hall, put forth for the first time by Johnson after he had been discharged from the service of the Interchangeable Tool Company.

In one aspect the decision of the case depends upon a question of time; that is to say, whether this model, (Exhibit C,) composed of brass and iron, was made when Johnson says it was, while he was a workman for Hall’s company, or at a date subsequent to Hall’s discharge of Johnson. Upon this question much testimony has been taken on both sides. Upon a full consideration of all the evidence my conclusion is that Exhibit C was not made when Johnson says it was, but subsequent to Johnson’s leaving the employment of the Interchangeable Tool Company, and that Moses C. Johnson was not the first inventor of the combination described in the patent issued to the plaintiff as assignee of Johnson. There must therefore be a decree dismissing the hill, with costs.
# C_2018063EN.01001901.xml

| 19.2.2018 | EN | Official Journal of the European Union | C 63/19 |
| --- | --- | --- | --- |

19.2.2018

EN

Official Journal of the European Union

C 63/19

---

Action brought on 22 December 2017 — Quadri di Cardano v Commission

(Case T-828/17)

(2018/C 063/25)

Language of the case: French

Parties

Parties

Applicant: Alessandro Quadri di Cardano (Alicante, Spain) (represented by: N. de Montigny and J.-N. Louis, lawyers)

Applicant:

Defendant: European Commission

Defendant:

Form of order sought

Form of order sought

Declare and rule:

| — | That the decision of the PMO of 28 February 2017 notifying the applicant that the expatriation allowance of 16 % granted to him and the transport expenses which he had received under Article 4 of Annex VII to the Staff Regulations, during the period of employment at EASME, with effect from 16 May 2014, is annulled; |
| --- | --- |

—

That the decision of the PMO of 28 February 2017 notifying the applicant that the expatriation allowance of 16 % granted to him and the transport expenses which he had received under Article 4 of Annex VII to the Staff Regulations, during the period of employment at EASME, with effect from 16 May 2014, is annulled;

| — | Insofar as necessary, that the salary slips corrected following the notification of that decision [are annulled]; |
| --- | --- |

—

Insofar as necessary, that the salary slips corrected following the notification of that decision [are annulled];

| — | That the defendant shall pay the costs. |
| --- | --- |

—

That the defendant shall pay the costs.

Pleas in law and main arguments

Pleas in law and main arguments

In support of the action, the applicant relies on two pleas in law.

| 1. | First plea in law, alleging infringement of Article 85 of the Staff Regulations of Officials of the European Union. |
| --- | --- |

1.

First plea in law, alleging infringement of Article 85 of the Staff Regulations of Officials of the European Union.

| 2. | Second plea in law, alleging infringement of the principle of legitimate expectations and the principle of legal certainty, a manifest error of assessment and infringement of the principle of sound administration. |
| --- | --- |

2.

Second plea in law, alleging infringement of the principle of legitimate expectations and the principle of legal certainty, a manifest error of assessment and infringement of the principle of sound administration.

---
# C_2020077EN.01000202.xml

| 9.3.2020 | EN | Official Journal of the European Union | C 77/2 |
| --- | --- | --- | --- |

9.3.2020

EN

Official Journal of the European Union

C 77/2

---

Judgment of the Court (Fourth Chamber) of 22 January 2020 — PTC Therapeutics International Ltd v European Medicines Agency, European Confederation of Pharmaceutical Entrepreneurs (Eucope)

(Case C-175/18 P) (1)

(Appeal - Access to documents of EU institutions, bodies, offices or agencies - Regulation (EC) No 1049/2001 - First indent of Article 4(2) - Exception relating to the protection of commercial interests - Article 4(3) - Protection of the decision-making process - Documents submitted to the European Medicines Agency in the context of a marketing authorisation application for a medicinal product for human use - Decision to grant a third party access to the documents - General presumption of confidentiality - No obligation for an EU institution, body, office or agency to apply a general presumption of confidentiality)

(2020/C 77/03)

Language of the case: English

Parties

Appellant: PTC Therapeutics International Ltd (represented by: G. Castle, B. Kelly, and K. Ewert, Solicitors, and by C. Thomas, Barrister, and M. Demetriou QC)

Other parties to the proceedings: European Medicines Agency (initially represented by: T. Jabłoński, S. Marino, S. Drosos, A. Spina and A. Rusanov, and subsequently by T. Jabłoński, S. Marino and S. Drosos, acting as Agents), European Confederation of Pharmaceutical Entrepreneurs (Eucope) (represented by: S. Cowlishaw, Solicitor, and D. Scannell, Barrister)

Operative part of the judgment

The Court:

| 1. | Dismisses the appeal; |
| --- | --- |

1.

Dismisses the appeal;

| 2. | Orders PTC Therapeutics International Ltd to bear its own costs and to pay those incurred by the European Medicines Agency (EMA); |
| --- | --- |

2.

Orders PTC Therapeutics International Ltd to bear its own costs and to pay those incurred by the European Medicines Agency (EMA);

| 3. | Orders the European Confederation of Pharmaceutical Entrepreneurs to bear its own costs. |
| --- | --- |

3.

Orders the European Confederation of Pharmaceutical Entrepreneurs to bear its own costs.

---

(1)  OJ C 231, 2.7.2018.

---
June 29, 2023

Re: Weekly Notification of Rule Amendments –

Updates to Risk Parameters Established by ICC 

Pursuant to Section 5c(c)(1) of the Commodity 

Exchange Act and Commission Regulation 40.6(d)

VIA ELECTRONIC PORTAL

Mr. Christopher Kirkpatrick

Secretary

Commodity Futures Trading Commission

Three Lafayette Centre

1155 21st Street, NW

Washington, D.C. 20581

Dear Mr. Kirkpatrick:

ICE Clear Credit (“ICC”) hereby submits, pursuant to Section 5c(c)(1) of the Commodity Exchange Act and Commodity 

Futures Trading Commission (“Commission”) Regulation 40.6(d), a notification of changes to risk parameters 

established by ICC in consultation with the ICC Risk Committee, Trading Advisory Group and/or Risk Working Group. 

ICC is registered with the Commission as a derivatives clearing organization.

The purpose of this notification is to report any changes to the risk parameters established by ICC. During the week 

ending June 30, 2023, changes were made to the following parameters: 

• Recovery Rates (RR) update for one EU Single Name Risk Factor

• bid/offer widths for CDX and iTraxx credit indices

• concentra�on charge thresholds for index and single name risk factors

• Kendall Tau rank-order correla�ons for NA, EU, Asia/Pacific (“AP”), and Emerging Market (“EM”) risk

factors

• MAD es�mates (inclusive of EWMA) for NA, EU, AP, and EM risk factors

• le� and right tail parameters for NA, EU, AP, and EM risk factors

ICC has posted a copy of this submission on its website concurrent with this filling. 

ICC would be pleased to respond to any questions the Commission or the staff may have regarding this submission. 

Please direct any questions or requests for information to the attention of the undersigned at olivia.bazor@ice.com

or 904-855-5580.

Sincerely,

Olivia Bazor

Staff Attorney
**Exhibit 13.1**
**CERTIFICATION**
Pursuant to 18 U.S.C. § 1350, the undersigned officer of Intelsat, Ltd. (the“Company”) hereby certifies that to such officer’s knowledge the Company’sannual report on Form 20-F for the year ended December 31, 2003 (the “Report”)fully complies with the requirements of Section 13(a) or 15(d), as applicable,of the Securities Exchange Act of 1934 and that the information contained inthe Report fairly presents, in all material respects, the financial conditionand results of operations of the Company.   Dated: March12, 2004 /s/ Conny Kullman   Conny KullmanChief Executive Officer
     The foregoing certification is being furnished solely pursuant to 18U.S.C. § 1350 and is not being filed as part of the Report or as a separatedisclosure document.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Defense

###### Department of the Air Force

The Buried Target Panel Meeting will meet in Pasadena, California on May 24, 2001 from 8 a.m. to 5 p.m.

The purpose of the meeting is to receive briefings and discuss the direction of the study. The meeting will be closed to the public in accordance with section 552b(c) of Title 5, United States Code, specifically subparagraphs (1) and (4) thereof.

For further information, contact the HQ USAF Scientific Advisory Board Secretariat at (703) 697-8404.

Janet A. Long,

Air Force Federal Register Liaison Officer.

[FR Doc. 01-12449 Filed 5-16-01; 8:45 am]

BILLING CODE 5001-05-P